600 patients66,869 observations120 daysLIVE

Patient P-01699

Synthetic patientNBL-101 · Day 112 · 55–64 · M · baseline S04Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Improving
GI state
Deteriorating
Inflammatory state
Stable
Nutritional resilience
Improving
Discontinuation risk
59%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S04
  2. Day 80 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 82 GI-04 recommendedGI Support Protocol GI-04
  4. Day 83 Patient acceptedStarted GI-04 in the companion
  5. Day 91 GI symptom burden −24% vs expectedGI Support Protocol GI-04
  6. Day 97 Tolerance state changedUnstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 80.

Primary contributors, last 14 days
  • GI instability+10
  • Toxicity-7
  • Treatment adherence-6
  • Nutritional resilience+4

What helped?

  • GI Support Protocol GI-04Day 82
    Result: symptom burden −24%
LIFE OS recommendation
Dietary Support Protocol NP-02
66%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 86% showed improvement
  • median effect visible after 10 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
52.6/100
stable · +1.2 vs previous 14 d
Toxicity
Blood
47.8/100
worsening · +5.4 vs previous 14 d
Sleep quality
Wearable
41.8/100
improving · +2.0 vs previous 14 d
Energy level
Daily log
3.9/10
worsening · -0.3 vs previous 14 d
Stress level
Daily log
6.2/10
worsening · +0.8 vs previous 14 d
Steps
Wearable
8,557
stable · +23 vs previous 14 d
Adherence
Companion
77.2 %
worsening · -11.1 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 50 from the failing basin, 46 from restoration.

Would help
  • ME-01 Monitoring Escalation
    100% improved among 62 similar · onset 3 d · confidence 62%
  • NP-02 Dietary Support Protocol
    70% improved among 54 similar · onset 10 d · confidence 62%
  • SC-12 Supportive Compound
    79% improved among 47 similar · onset 6 d · confidence 62%
Would not help
  • Keep simple carbs low
    GI +5 next day on high-intake days · n 15
  • Keep fibre low
    GI +3.4 next day on high-intake days · n 20
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Simple carbohydrates
    +5detractor · 95%
  • Insoluble fibre
    +3.4detractor · 59%
  • Spicy / capsaicin
    -1.2no signal · 16%
  • Dietary fat load
    +0.9no signal · 15%
  • Alcohol
    -0.6no signal · 15%
  • Histamine load
    -0.2no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Inflammatory signalling 70
    • DNAIL6 -174 variant raises baseline inflammatory tone
    • MicrobiomeBacteroides fragilis expansion
    • BloodInflammatory load index 51
  • Drug metabolism and exposure 55
    • DNADPYD *2A → slower clearance
    • BloodToxicity index 48
  • Mucosal barrier integrity 50
    • MicrobiomeAkkermansia low → thinner mucus layer
    • Daily logGI symptom score 53 and rising
  • Butyrate / short-chain fatty acid production 45
    • MicrobiomeF. prausnitzii depleted
    • Daily logFibre intake low in recent food logs
  • Autonomic recovery 25
    • WearableResting HR 85 bpm
DNA
Fictional pharmacogenomic panel
  • IL6 -174 G/C
    Higher inflammatory tone
  • DPYD *2A heterozygous
    Slower drug clearance
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 2 · butyrate capacity 47/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisHigh
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
38 ms
Sleep
7.2 h
Steps
7,503
Resting HR
85 bpm
Daily log: GI score 53, nutritional resilience 43, adherence 77.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • Keep the current walking rhythm
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0155824%S0986
P-0144824%S1083
P-0167624%S0381
P-0180325%S1181
P-0148424%S1881
P-0150325%S15ME-01improved80
P-0155124%S0480
P-0147124%S1979
P-0130625%S0279
P-0135326%S0775
P-0189627%S0775
P-0157724%S20HY-01no change74